Law360, New York (June 14, 2010, 1:30 PM EDT) -- Reckitt Benckiser Inc. has updated a patent infringement suit against Tris Pharma Inc. over a proposed generic version of its Delsym 7 cough suppressant to include trade secrets misappropriation and unfair competition claims against Tris and one of its vice presidents, who previously worked for RBI's licensing partner.
RBI lodged an amended complaint Friday in the U.S. District Court for the District of New Jersey, updating its allegations against Tris, a direct rival.
RBI's original complaint, filed in June 2009, accused Tris of infringing U.S. Patent...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.